Inventor · disambiguated record
Lauren Otsuki
Also filed as: OTSUKI LAUREN
1 granted patent·9 pending applications·0 citations·filing 2004–2023
14Inventor score
Files withOTSUKI LAUREN2WIDDER KENNETH J2DIAKRON PHARMACEUTICALS INC1DITTRICH HOWARD C1GLO PHARMA INC1
Top patents by PatentIndex Score
10 records- 0155US2024041740A1Skin peel compositionsGLO PHARMA INC·Filed 2023·Application pending·0 cites
- 0254US2024309104A1Compositions comprising humanized antibodies to tnf-like ligand 1a (tl1a) and uses thereofPROMETHEUS BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 0349US2009253665A1Method of treatment of disease using an adenosine a1 receptor antagonist and an aldosterone inhibitorOTSUKI LAUREN·Filed 2009·Application pending·0 cites
- 0449US2009118334A1Method of treatment of cardiac and/or renal failure using a calcium channel blocker and an angiotensin converting enzyme inhibitor or an angiotensin ii receptor blockerDIAKRON PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 0543US2006030572A1Method of improved diuresis in individuals with impaired renal functionWIDDER KENNETH J·Filed 2005·Application pending·0 cites
- 0643US2006035911A1Method of improved diuresis in individuals with impaired renal functionWIDDER KENNETH J·Filed 2005·Application pending·0 cites
- 0742US7579331B2Method of improved diuresis in individuals with impaired renal functionNOVACARDIA INC·Filed 2004·Granted Aug 25, 2009·0 cites·51 claims
- 0839US2006058355A1Method of treatment of cardiac and/or renal failure using a calcium channel blocker and an angiotensin converting enzyme inhibitor or an angiotensin II receptor blockerDITTRICH HOWARD C·Filed 2005·Application pending·0 cites
- 0938US2005239759A1Method of treatment of disease using an adenosine A1 receptor antagonist and an aldosterone inhibitorOTSUKI LAUREN·Filed 2005·Application pending·0 cites
- 1033US2004229901A1Method of treatment of disease using an adenosine A1 receptor antagonistFiled 2004·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →